Patents by Inventor Clare Louise Anderton

Clare Louise Anderton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of a pyridine derivative
    Patent number: 8093242
    Abstract: The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: January 10, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Clare Louise Anderton, Ronnie Maxwell Lawrence, David Clapham
  • Crystalline Forms Of A Pyridine Derivative
    Publication number: 20110136798
    Abstract: The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
    Type: Application
    Filed: August 4, 2009
    Publication date: June 9, 2011
    Inventors: Clare Louise Anderton, Ronnie Maxwell Lawrence, David Clapham
  • Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist
    Publication number: 20100317672
    Abstract: The present invention relates to a monomaleate monohydrate salt of 7-methyl-6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4,5-dihydroimidazo[1,5-a]quinoline-3-carboxamide, uses of the salt as a medicament in the treatment of sexual dysfunction and pharmaceutical compositions and dosage forms comprising the salt.
    Type: Application
    Filed: January 15, 2009
    Publication date: December 16, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Clare Louise Anderton, Grahame Robert Woollam